Webinars

Biointron has established an industry-leading 2-week antibody production service, supported by a powerful high-throughput expression platform.

This topic explores the revolutionary potential of the genome-edited mouse HUGO-Ab, where endogenous VH and VL genes are replaced by fully human VH and VL genes in situ, enabling the generation of fully human antibody molecules.

Biointron's SVP of R&D, Lei Shi, PhD, discussed the processes of accelerating early discovery through HTP and high-speed antibody production during the Antibody Engineering & Therapeutics US 2023 conference in San Diego. Below is a summary of the talk.

Talk Title: Innovative Multiple Tech & Platforms Empower Antibody DiscoverySpeaker: Dr.Long Xu, Director, R&D Strategy at BiointronBiointron is excited to announce our upcoming collaborative webinar with the Antibody Society, scheduled for September 26th, 2023. This webinar will featur

Talk Title: Innovative Multiple Tech & Platforms Empower Antibody DiscoverySpeaker: Dr.Long Xu, Director, R&D at BiointronBiointron is thrilled to announce our upcoming collaborative webinar with the Chinese Antibody Society, set to take place on September 16th from 9-10 PM EST (Septem

Together with the Chinese Antibody Society, Biointron's latest webinar features Shun Zhou, Ph.D, the R&D Director at Cyagen: “Accelerating Antibody Discovery with Fully Human Antibody Mouse HUGO-Ab™ and Single B Cell Screening Technology AbDrop™”